Zanosar (streptozocin) / Teva  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zanosar (streptozocin) / Teva
MK-0869-208, NCT01362530 / 2011-000651-16: A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants

Checkmark Aprepitant for the prevention of CINV in children
Mar 2015 - Mar 2015: Aprepitant for the prevention of CINV in children
Completed
3
307
NA
Aprepitant 125 mg, MK-0869, Emend®, Aprepitant 80 mg, Aprepitant powder for suspension (PFS), Ondansetron, Zofran™, Placebo for Aprepitant 125 mg, Placebo for Aprepitant 80 mg, Placebo for Aprepitant PFS, Emetogenic chemotherapy
Merck Sharp & Dohme LLC
Chemotherapy Induced Nausea and Vomiting
03/13
08/13

Download Options